Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by icecubeon Sep 28, 2015 3:25pm

53 Views

Post# 24142268

RE:RE:RE:RE:Catching a Knife?

Fraud? Corporate malfeasance? Those are pretty bold accusations to be making.

Maybe it does take a year to turn it around but at the current risk-reward potential I'll still be buying.

truthseeker2012 wrote: Confidence in management is gone due to corporate malfeasance. Yes maybe in 18 to 60 months things will turn around, but who is to say they won' t make another Innocutis type deal & increase their exec pay checks again?

There are no buyers that is why the price has not dropped everyone who wants to get out can't.

Who wants to wait at least 18 months for a turnaround? Unless they do new deals that are actually good & or management cuts its pay by at least 50% and or there are management firings, no one will buy.

If there is any buying it will only help to provide some liquidity for those who want out, which is pretty much everyone now. So any buying should actually help the price to drop further.